Impact Of Obesity On Tamoxifen Chemoprevention In A Model Of Ductal Carcinoma In Situ

Abstract

Obesity increases risk for breast cancer in postmenopausal women and increases mortality in pre- and postmenopausal women, in fact, 30-50% of breast cancer deaths in post-menopausal women may be attributed to excess body weight (1). The HER-2/neu proto-oncogene is amplified in 25-30% of human primary breast cancers, and increased levels of HER-2/neu expression in tumors can have a negative impact on prognosis of the cancer (2). Approximately two-thirds of breast cancers arising in postmenopausal women are positive for estrogen receptor (ER) in carcinoma cells. However, tumors negative for estrogen receptor (ER-) confer a much worse prognosis (3). Energy balance modulation through diet-induced obesity and calorie restriction has been shown to modulate serum levels of many growth factors and hormones, including estrogen. Additionally, energy balance modulation affects cancer initiation and progression multiple mouse and primate models (4). However, the specific mechanisms by which obesity affects ER- breast cancer risk or prognosis are not clearly understood, and strategies for offsetting the negative effects of obesity are urgently needed, so the purpose of my project is twofold. First, we will determine which obesity-related growth factors/hormones are key to tumor progression. Second, we will determine how blocking specific growth factors (specifically components of the IGF-I pathway) can decrease the negative effects of obesity on breast cancer and increase response to chemopreventive drugs (chemopreventive drugs are compounds given to prevent breast cancer, i.e. tamoxifen). This annual report summarizes the characterization of the effects of dietary energy balance modulation on metabolic hormones and mammary tumor development, growth, and progression in MMTV-neu (HER-2/neu overexpressing) mice (Specific Aim 1).

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2011
Accession Number
ADA555053

Entities

People

  • Sarah D. Smith

Organizations

  • University of Texas at Austin

Tags

DTIC Thesaurus Topics

  • Body Composition
  • Body Weight
  • Breast Cancer
  • Carcinoma
  • Carrier Proteins
  • Cell Physiological Processes
  • Cells
  • Chemistry
  • Department Of Defense
  • Growth Factors
  • Mammary Glands
  • Mass Spectrometry
  • Medical Personnel
  • Neoplasms
  • Stem Cells
  • Students
  • Training

Fields of Study

  • Medicine

Readers

  • Breast cancer cell signaling and growth regulation.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Molecular Biology and Genetics

Technology Areas

  • Biotechnology